• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX DUODENAL; STENT,METALLIC,EXPANDABLE,DUODENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX DUODENAL; STENT,METALLIC,EXPANDABLE,DUODENAL Back to Search Results
Device Problems Obstruction of Flow (2423); Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/01/2010
Event Type  Injury  
Manufacturer Narrative
Date of event: approximated based on the month and year the first procedures were performed.The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.The initial reporter's facility name is (b)(6).Report source: literature source: matsumoto, t., hino, k., terasawa, h., nakasya, a., uesugi, k., nishide, n., kajiwara, t., asagi, a., nishina, t., nasu, j., hori., s., nadano, s., ishii, h.Consideration of endoscopic stenting for gastroduodenal stenosis due to malignancy: through comparison with gastrojejunostomy.Palliative care research 2016; 11(2): 166-73.(b)(4).
 
Event Description
Boston scientific became aware of events through the article "consideration of endoscopic stenting for gastroduodenal stenosis due to malignancy: through comparison with gastrojejunostomy" by dr.Toshihiko matsumoto, et al.Both wallflex duodenal stents and non-boston scientific (taewoong niti-s) duodenal stents were used during the study and the stents were implanted to treat gastroduodenal stenosis due to unresectable malignancy during gastroduodenal stenting procedures performed between april 2010 and april 2015.25 patients were including in the stenting group of the study, with 6 implanted with wallflex duodenal stents and the other 19 implanted with non-boston scientific duodenal stents.According to the literature, two stents were noted to be occluded at 108 and 188 days post stent placement and the stents were repositioned.Another stent was found to have migrated 237 days post stent placement.It is unknown how the stent migration was resolved.Note: it is unknown whether the boston scientific wallflex duodenal stents or the non-boston scientific duodenal stents encountered the reported events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX DUODENAL
Type of Device
STENT,METALLIC,EXPANDABLE,DUODENAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14251995
MDR Text Key290447608
Report Number3005099803-2022-02210
Device Sequence Number1
Product Code MUM
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K062750
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-